Search Results for: Titrate

Exploring the Safety and Tolerability of Conversion From Oral or Injectable Disease Modifying Therapies to Dose-titrated Oral Siponimod in Patients With Advancing Forms of Relapsing Multiple Sclerosis: A 6-month Open Label, Multi-Center Phase IIIb Study

Exploring the Safety and Tolerability of Conversion From Oral or Injectable Disease Modifying Therapies to Dose-titrated Oral Siponimod in Patients With Advancing Forms of Relapsing Multiple Sclerosis: A 6-month Open Label, Multi-Center Phase IIIb Study

Multiple Sclerosis News
Publication date: Apr 04, 2019 To assess early phase safety and tolerability of converting patients from approved oral and injectable RMS DMTs to siponimod. Concepts Keywords DMT Multiple Sclerosis Healthcare ... Read more